Secondary analysis of an RCT in 189 patients with breast cancer: within true electroacupuncture, HTR3A rs909411 GG was linked to more complete protection from chemotherapy nausea and vomiting (62.3%) and COMT rs4633 to less; no SNP-by-treatment interaction.
Secondary analysisn = 189
Zheng et al. Association of HTR3A and COMT polymorphisms with electroacupuncture response for chemotherapy-induced nausea and vomiting in breast cancer: a secondary analysis of a randomized controlled trial